Clinical trial
Methotrexate Compared With Dactinomycin in Treating Patients With Gestational…
NCT00003702 · Gynecologic Oncology Group, Other · Completed
Key facts
| NCT number | NCT00003702 |
|---|---|
| Title | Methotrexate Compared With Dactinomycin in Treating Patients With Gestational Trophoblastic Neoplasia |
| Official title | A Randomized Phase III Trial of Weekly Parenteral Methotrexate Versus "Pulsed" Dactinomycin as Primary Management for Low Risk Gestational Trophoblastic Neoplasia |
| Lead sponsor | Gynecologic Oncology Group, Other |
| Collaborators | Eastern Cooperative Oncology Group National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Good Prognosis Metastatic Gestational Trophoblastic Tumor, Hydatidiform Mole, Non-Metastatic Gestational Trophoblastic Tumor, Uterine Corpus Choriocarcinoma |
| Intervention type | Biological, Drug |
| Interventions | Dactinomycin, Methotrexate |
| Enrollment | 240 |
| Start date | Jun 1, 1999 |
| Primary completion | Jul 1, 2010 |
| First posted | Jan 27, 2003 |
| Last update posted | May 15, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: